Who is this for?
GeneGenius is designed for teams who need faster, more reliable genomic interpretation.
Clinical Genomics Labs
CLIA-certified and research laboratories seeking faster, more consistent variant interpretation workflows.
Hospital Genomics Programs
Health systems building or scaling clinical genomics services with limited bioinformatics staff.
Oncology Diagnostics Teams
Molecular tumor boards and precision oncology teams interpreting somatic and germline variants.
Rare Disease Research Groups
Academic and clinical researchers analyzing whole-exome and whole-genome sequencing for rare disease diagnosis.
Where genomic interpretation
drives decisions
From rare disease diagnostics to precision oncology, structured AI‑driven interpretation supports confident clinical action.
Diagnostic Clarity
Accelerate the interpretation of variants in rare disease cases. Reduce uncertainty by synthesizing evidence from literature, functional studies, and clinical databases to support diagnostic decisions.
Therapy Relevance
Identify actionable variants linked to targeted therapies, clinical trials, and treatment guidelines. Connect tumor genomics to evidence based therapeutic options.
Treatment Response
Interpret pharmacogenomic variants that affect drug metabolism and efficacy. Align findings with CPIC guidelines to support medication selection and dosing decisions.
PharmGKB